MARÍA PILAR
ESCRIBANO SUBÍAS
Profesora asociada de Ciencias de la Salud
Hospital Universitario Central de Asturias
Oviedo, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario Central de Asturias (15)
2024
-
Risk Stratification in Pulmonary Veno-Occlusive Disease
Archivos de Bronconeumologia
2023
-
Usefulness of genetics for clinical reclassification and refinement of prognostic stratification in pulmonary arterial hypertension
Revista Espanola de Cardiologia, Vol. 76, Núm. 6, pp. 460-467
2022
-
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)
Scientific Reports
-
Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry
Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 260-266
-
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
Scientific reports, Vol. 12, Núm. 1, pp. 5289
2021
-
Azole and amphotericin B MIC values against aspergillus fumigatus: High agreement between spectrophotometric and visual readings using the EUCAST EDef 9.3.2 procedure
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1
-
Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain
Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7
-
From Health-Related Quality of Life (HRQoL) of Patients with Pulmonary Hypertension to Patient Experience with the Care Received: Should We Be More Aware of Current Patient Needs?
Advances in Therapy, Vol. 38, Núm. 4, pp. 1860-1875
2019
-
Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry
International Journal of Cardiology, Vol. 275, pp. 158-164
2018
-
Variable Expressivity of a Founder Mutation in the EIF2AK4 Gene in Hereditary Pulmonary Veno-occlusive Disease and Its Impact on Survival
Revista Espanola de Cardiologia, Vol. 71, Núm. 2, pp. 117-118
2016
2015
-
A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies
Clinical Genetics, Vol. 88, Núm. 6, pp. 579-583
2014
-
Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?
International Journal of Cardiology, Vol. 171, Núm. 1, pp. 15-23
2013
-
Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation
Clinical Transplantation, Vol. 27, Núm. 6